tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Autolus: Short-Term Revenue Miss, Long-Term Blockbuster Potential Supports Buy Rating
PremiumRatingsAutolus: Short-Term Revenue Miss, Long-Term Blockbuster Potential Supports Buy Rating
1M ago
Maintaining Buy on Autolus: Solid Aucatzyl Growth and Extended Cash Runway Support Attractive Risk‑Reward Despite Lowered Targets
Premium
Ratings
Maintaining Buy on Autolus: Solid Aucatzyl Growth and Extended Cash Runway Support Attractive Risk‑Reward Despite Lowered Targets
1M ago
Autolus Therapeutics price target lowered to $10 from $11 at Needham
Premium
The Fly
Autolus Therapeutics price target lowered to $10 from $11 at Needham
1M ago
Autolus Therapeutics to evaluate automated manufacturing of AUCATZYL
PremiumThe FlyAutolus Therapeutics to evaluate automated manufacturing of AUCATZYL
1M ago
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
Premium
The Fly
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal
2M ago
Needham ups Autolus target, names top pick for 2026
Premium
The Fly
Needham ups Autolus target, names top pick for 2026
2M ago
Autolus Therapeutics announces NICE draft guidance recommending Aucatzyl
PremiumThe FlyAutolus Therapeutics announces NICE draft guidance recommending Aucatzyl
3M ago
Autolus Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Autolus Therapeutics Reports Q3 2025 Financial Results
3M ago
Autolus Therapeutics’ Earnings Call: Mixed Sentiments
Premium
Company Announcements
Autolus Therapeutics’ Earnings Call: Mixed Sentiments
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100